started · updated
Thalassemia patients in Iran face soaring treatment costs
Thalassemia patients in Iran are facing a severe crisis due to skyrocketing medical costs. Salman Eshaghi, spokesperson for the Parliament's Health and Treatment Commission, reported that monthly expenses for medication and treatment for a single patient have reached approximately 150 million tomans.
Eshaghi noted that out-of-pocket costs for these patients have increased by as much as 700 times. This surge is attributed to fluctuations in exchange rates and changes in how currency is calculated for certain medicines and medical equipment, as well as delays in settling pharmacy claims.
Beyond thalassemia, broader economic pressures are impacting the national healthcare system. Rising living costs are forcing many individuals to delay or entirely abandon necessary medical treatments, potentially leading to more severe health complications and increased long-term burdens on the healthcare infrastructure.
Entities
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 2 SOURCES] Monthly medication and treatment costs for a thalassemia patient have reached approximately 150 million tomans. negarmag.com · aftabnews.ir
- [○ 1 SOURCE] Rising living costs are forcing some patients to delay or abandon medical treatments. melliun.org
- [● 2 SOURCES] Delays in paying pharmacy claims are a major problem for patients. negarmag.com · aftabnews.ir
- [● 2 SOURCES] Changes in exchange rate calculations for certain medicines and medical equipment occurred in Azar 1404. negarmag.com · aftabnews.ir
- [● 2 SOURCES] Out-of-pocket expenses for thalassemia patients have increased by up to 700 times. negarmag.com · aftabnews.ir